Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

NCT03605862 is registered in ClinicalTrials.gov with Romark Laboratories L.C. as lead sponsor.

NCT NCT03605862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03605862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Lead sponsor
Romark Laboratories L.C.
Phase
Phase 3
Overall status
Completed
Start date
September 11, 2018
Completion date
February 4, 2019
Enrollment
1,756 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

enterovirus, rhinovirus